Analysis of C-Kit Exon 9, Exon 11 and BRAFV600E Mutations Using Sangers Sequencing in Gastrointestinal Stromal Tumours

Cureus
doi 10.7759/cureus.7369
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cureus, Inc.

Related search

Canine and Human Gastrointestinal Stromal Tumors Display Similar Mutations in C-Kit Exon 11

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

KIT Expression in Angiosarcomas and Fetal Endothelial Cells: Lack of Mutations of Exon 11 and Exon 17 of C-Kit

Modern Pathology
Forensic MedicinePathology
2000English

Unlucky Number 13? Differential Effects of KIT Exon 13 Mutation in Gastrointestinal Stromal Tumors

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2008English

Double Resistance to Imatinib and AMG 706 Caused by Multiple Acquired KIT Exon 17 Mutations in a Gastrointestinal Stromal Tumour

Gut
Gastroenterology
2007English

Clinical Benefit of Sunitinib in Gastrointestinal Stromal Tumors With Different Exon 11 Mutation Genotypes

Future Oncology
MedicineCancer ResearchOncology
2017English

Complementary Activity of Tyrosine Kinase Inhibitors Against Secondary Kit Mutations in Imatinib-Resistant Gastrointestinal Stromal Tumours

British Journal of Cancer
Cancer ResearchOncology
2019English

Prognostic Value of KIT/PDGFRA Mutations in Gastrointestinal Stromal Tumors: A Meta-Analysis

World Journal of Surgical Oncology
SurgeryOncology
2014English

Germline Mutations of KIT in Gastrointestinal Stromal Tumor (GIST) and Mastocytosis

Cell and Bioscience
BiochemistryGeneticsMolecular Biology
2016English

Correction: Complementary Activity of Tyrosine Kinase Inhibitors Against Secondary Kit Mutations in Imatinib-Resistant Gastrointestinal Stromal Tumours

British Journal of Cancer
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy